Home > Back to Publisher > Report Information

U.S. Arthritis Therapies Markets

Frost & Sullivan
May 25, 2004
SKU: MC1002543

Abstract Table of Contents Related Reports

Countries covered: United States

The high price of biological response modifiers (BRMs) open exciting opportunities for arthritis drug manufacturers, while their exceptional clinical performance offers hope to millions suffering from the disease. Though profitable for manufacturers, the annual BRM treatment cost of over $10,000 proves prohibitive for most patients. However, with its ability to curb joint degeneration and restore normality in motion and functioning, most patients are willing to take on debts and mortgages in order to meet the high costs that most managed care plans refuse to cover. Significantly lower-priced disease-modifying anti-rheumatic drugs (DMARDs) are a viable alternative for arthritis patients, but fail to provide the numerous benefits of BRMs. DMARDs also come with several drawbacks such as higher toxicity caused by prolonged usage and the inability to reverse the effects of rheumatoid arthritis. Additionally, with the entry of lower-priced and improved drugs that offer convenient dosing and easier administration, prices of BRMs are likely to fall in order to meet the growing competition.

This research service analyzes the key drivers and challenges influencing the U.S. arthritis therapies market. Product and pricing trends coupled with patient and revenue forecasts enable participants to formulate a structured marketing plan. Product trends and pipeline analysis give an insight into future opportunities in various product segments such as BRMs, DMARDs, COX-2 inhibitors (COX-2s), and other non-steroidal anti-inflammatory drugs (NSAIDs). Market share and competitive analysis throw light on essential strategies to achieve success in the competitive arthritis therapies market.


1  EXECUTIVE SUMMARY     
 
  Executive Summary     
 
   Executive Summary   
 
2  TOTAL U.S. ARTHRITIS THERAPIES MARKET     
 
  Overview     
 
   Introduction   
   Methodology   
   Market Overview and Definition   
 
  Report Scope and Market Segmentation     
 
   Scope and Segmentation   
   Market Engineering Measurement Analysis for Total Market   
 
  Market Demand and Forecasts     
 
   Introduction   
   Patient Forecasts   
   Pricing Forecasts   
   Revenue Forecasts   
 
  Competitive Analysis     
 
   Competitive Landscape   
   Market Share   
   Industry Issues and Challenges   
 
  Frost and Sullivan Awards     
 
   Company of the Year Award   
   Technology Innovation Award   
   Research and Development Excellence Award   
 
3  BIOLOGICAL RESPONSE MODIFIERS ARTHRITIS THERAPIES MARKET     

  Segment Highlights     
 
   Segment Highlights   
 
  Overview     
 
   Introduction   
   Biologic Response Modifier Market Engineering Measurement Analysis   
   Segment Issues   
 
  Market Demand and Forecasts     
 
   Revenue Analysis and Market Size   
 
  Market Trends     
 
   Factors Affecting Market Growth   
   Product Trends   
   Pricing Trends   
 
  Competitive Analysis     
 
   Competitive Landscape   
   Pipeline Analysis   
   Market Share   
 
4  NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET     

  Segment Highlights     
 
   Segment Highlights   
 
  Overview     
 
   Introduction   
   Non-Steroidal Anti-Inflammatory Drug Market Engineering Measurement Analysis   
   Segment Issues   
 
  Market Demand and Forecasts     
 
   Revenue Analysis and Market Size   
 
  Market Trends     
 
   Factors Affecting Market Growth   
   Product Trends I   
   Product Trends II   
   Pricing Trends   
 
  Competitive Analysis     
 
   Competitive Landscape   
   Pipeline Analysis   
   Market Share   
 
5  DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS MARKET     

  Segment Highlights     
 
   Segment Highlights   
 
  Overview     
 
   Introduction   
   Disease Modifying Anti-Rheumatic Drug (DMARD) Arthritis Therapies Market Engineering Measurement Analysis   
   Segment Issues   
 
  Market Demand and Forecasts     
 
   Revenue Analysis and Market Size   
 
  Market Trends     
 
   Factors Affecting Market Growth   
   Product Trends   
   Pricing Trends   
 
  Competitive Analysis     
 
   Competitive Landscape   
   Pipeline Analysis   
   Market Share   
 
6  APPENDIX     

  Decision Support Databases     
 
   Arthritis Prevalence   
   Population 55 and above   
   Biotechnology Companies   
   Hospital Beds   
   Obese Population

More United States Arthritis Reports

Anti-Inflammatory Therapeutics Market to 2017 - Respiratory Diseases and Arthritis Continue to Dominate by GBI Research
Anti-Inflammatory Therapeutics Market to 2017 - Respiratory Diseases and Arthritis Continue to Dominate Summary GBI Research, the leading business intelligence provider, has released its latest research, “Anti-Inflammatory ...

Executive Summary: Psoriasis and Psoriatic Arthritis: A Strategic Analysis of the Market in the United States by Kalorama Information Executive Summaries
Kalorama Information's Executive Summaries provide a comprehensive overview of the contents contained in our full-length market intelligence reports. Containing a snapshot of the ...

Psoriasis and Psoriatic Arthritis: A Strategic Analysis of the Market in the United States by Kalorama Information
This report focuses on the applications of current and advanced therapeutics to the treatment of psoriasis and psoriatic arthritis, the options they present, and the ...

NBJ's Joint Health Report 2006 by Nutrition Business Journal
NBJ's Joint Health Report 2006 provides a strategic and quantitative assessment of the market for joint health products in the United States. This 40-page ...

Chronic Pain Management Programs: A Market Analysis by Marketdata Enterprises Inc.
Nearly 4,000 facilities and solo practitioners (clinics and centers, anesthesiologists, chiropractors, biofeedback specialists) treat 5+ million Americans suffering from chronic back pain, migraines, cancer, irritable ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>

U.S. Arthritis Therapies Markets

Share this report

Other tasks

Research Assistance

Related Markets

Arthritis Reports

Free Alert Me service